Synthesis Of Novel Benzoxanthone Analogues As Non-Camptothecin Topoisomerase I Inhibitors

Pengfei Cheng,Lingjian Zhu,Wei Guo,Wenfeng Liu,Jianzhong Yao,Guoqiang Dong,Yongqiang Zhang,Chunlin Zhuang,Chunquan Sheng,Zhenyuan Miao,Wannian Zhang
DOI: https://doi.org/10.3109/14756366.2011.595712
2012-01-01
Journal of Enzyme Inhibition and Medicinal Chemistry
Abstract:Structure modification of the side chain of the lead compound benzoxanthone provided a series of benzoxanthone analogues and 12 of them were first reported. The results showed that most of these compounds had moderate cytotoxicity against tumour cells with the 50% inhibition concentration in the micromolar range. Furthermore, benzoxanthone derivatives 5, 6c, 7a and 7e, showed potent topoisomerase I (Topo I) inhibitory effect and the results indicated that some compounds had potential for development as non-Camptothecin (CPT) topoisomerase I inhibitors.
What problem does this paper attempt to address?